首页> 外文期刊>Lipids in Health Disease >13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages
【24h】

13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages

机译:13-羟基亚油酸可增加RAW264.7巨噬细胞中胆固醇转运蛋白ABCA1,ABCG1和SR-BI的表达并刺激apoA-I依赖性胆固醇外流

获取原文
           

摘要

Background Synthetic activators of peroxisome proliferator-activated receptors (PPARs) stimulate cholesterol removal from macrophages through PPAR-dependent up-regulation of liver × receptor α (LXRα) and subsequent induction of cholesterol exporters such as ATP-binding cassette transporter A1 (ABCA1) and scavenger receptor class B type 1 (SR-BI). The present study aimed to test the hypothesis that the hydroxylated derivative of linoleic acid (LA), 13-HODE, which is a natural PPAR agonist, has similar effects in RAW264.7 macrophages. Methods RAW264.7 macrophages were treated without (control) or with LA or 13-HODE in the presence and absence of PPARα or PPARγ antagonists and determined protein levels of LXRα, ABCA1, ABCG1, SR-BI, PPARα and PPARγ and apolipoprotein A-I mediated lipid efflux. Results Treatment of RAW264.7 cells with 13-HODE increased PPAR-transactivation activity and protein concentrations of LXRα, ABCA1, ABCG1 and SR-BI when compared to control treatment (P < 0.05). In addition, 13-HODE enhanced cholesterol concentration in the medium but decreased cellular cholesterol concentration during incubation of cells with the extracellular lipid acceptor apolipoprotein A-I (P < 0.05). Pre-treatment of cells with a selective PPARα or PPARγ antagonist completely abolished the effects of 13-HODE on cholesterol efflux and protein levels of genes investigated. In contrast to 13-HODE, LA had no effect on either of these parameters compared to control cells. Conclusion 13-HODE induces cholesterol efflux from macrophages via the PPAR-LXRα-ABCA1/SR-BI-pathway.
机译:背景过氧化物酶体增殖物激活受体(PPAR)的合成激活剂通过依赖PPAR上调肝脏×受体α(LXRα)并随后诱导胆固醇输出分子(如ATP结合盒转运蛋白A1(ABCA1)和清除剂受体B类1型(SR-BI)。本研究旨在检验以下假设:亚油酸(LA)的羟基化衍生物13-HODE是天然PPAR激动剂,在RAW264.7巨噬细胞中具有相似的作用。方法在存在或不存在PPARα或PPARγ拮抗剂的情况下,在无(对照)或LA或13-HODE的条件下处理RAW264.7巨噬细胞,测定LXRα,ABCA1,ABCG1,SR-BI,PPARα和PPARγ的蛋白水平以及载脂蛋白AI介导脂质外流。结果与对照组相比,用13-HODE处理RAW264.7细胞可提高PPAR的激活活性以及LXRα,ABCA1,ABCG1和SR-BI的蛋白质浓度(P <0.05)。另外,在细胞与细胞外脂质受体载脂蛋白A-I孵育的过程中,13-HODE可增加培养基中的胆固醇浓度,但降低细胞胆固醇浓度(P <0.05)。用选择性PPARα或PPARγ拮抗剂预处理细胞完全消除了13-HODE对所研究基因的胆固醇外流和蛋白质水平的影响。与13-HODE相比,LA与对照细胞相比对这些参数均无影响。结论13-HODE通过PPAR-LXRα-ABCA1/ SR-BI途径诱导巨噬细胞胆固醇外流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号